Clonazepam
- Product NDC
- 43353-799
- 11-digit product format
- 433530799
- Labeler code
- 43353
- Product ID
- 43353-799_12b95e60-10f9-423f-9838-b2f514637f39
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- clonazepam
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Application
- ANDA077856
- Marketing category
- ANDA
- Marketing start
- 2006-06-28
- Marketing end
- 0000-00-00
- Substance
- CLONAZEPAM
- Active strength
- 2 mg/1
- Pharmacologic classes
- Benzodiazepine [EPC],Benzodiazepines [CS]
- DEA schedule
- CIV
- NDC exclude flag
- No
- Listing certified through
- 2019-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 43353-799-15 | Clonazepam | 15 in 1 BOTTLE, PLASTIC | TABLET | 15 | | 2 |
| 43353-799-45 | Clonazepam | 45 in 1 BOTTLE, PLASTIC | TABLET | 45 | | 2 |
| 43353-799-70 | Clonazepam | 120 in 1 BOTTLE, PLASTIC | TABLET | 120 | | 2 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| CLONAZEPAM | ACTIVE INGREDIENT | 5PE9FDE8GB | CLONAZEPAM TABLET [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC] | 2 | |
| CLONAZEPAM | ACTIVE MOIETY | 5PE9FDE8GB | CLONAZEPAM TABLET [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC] | 2 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | CLONAZEPAM TABLET [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC] | 2 | |
| CROSCARMELLOSE SODIUM | INACTIVE INGREDIENT | M28OL1HH48 | CLONAZEPAM TABLET [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC] | 2 | |
| FD&C BLUE NO. 1 | INACTIVE INGREDIENT | H3R47K3TBD | CLONAZEPAM TABLET [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC] | 2 | |
| LACTOSE MONOHYDRATE | INACTIVE INGREDIENT | EWQ57Q8I5X | CLONAZEPAM TABLET [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC] | 2 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | CLONAZEPAM TABLET [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC] | 2 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | CLONAZEPAM TABLET [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC] | 2 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 43353-799 | CLONAZEPAM TABLET [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC] | 2 | Legacy NDC, 3 package rows | 20140422_f868dfce-6ef4-4e08-89b1-2e4018ecd9c5.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Status |
|---|
| 43353-799-15 | 43353079915 | 15 in 1 BOTTLE, PLASTIC | Historical |
| 43353-799-45 | 43353079945 | 45 in 1 BOTTLE, PLASTIC | Historical |
| 43353-799-70 | 43353079970 | 120 in 1 BOTTLE, PLASTIC | Historical |